CIBC World Markets »

Intellia Therapeutics shares owned by CIBC World Markets

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by CIBC World Markets from 13F filings

Historical chart of CIBC World Markets investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by CIBC World Markets

Quarter filed Position value Share count Share price at filing
2025-06-30 $108k 12k 9.38
2025-03-31 $132k 19k 7.11
2024-12-31 $234k 20k 11.66
2024-09-30 $337k 16k 20.54
2024-06-30 $405k 18k 22.37
2024-03-31 $557k 20k 27.52
2023-09-30 $487k 15k 31.63
2023-06-30 $592k 15k 40.76
2023-03-31 $288k 7.7k 37.25
2022-12-31 $296k 8.5k 34.84
2022-09-30 $450k 8.0k 55.94
2022-06-30 $468k 9.0k 51.80
2022-03-31 $344k 4.7k 72.57
2021-12-31 $380k 3.2k 118.09
2021-09-30 $331k 2.5k 134.23
2021-06-30 $512k 3.2k 161.92
2021-03-31 $422k 5.3k 80.23